Date: 06 August 2026
Regulatory Compliance Update
Sun Pharmaceutical Industries Limited has received formal no-objection letters from both National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) dated 06 August 2026.
The approval grants permission for the reclassification of three promoter group members from the 'Promoter Group' category to the 'Public' category in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Individuals Subject to Reclassification
The following three individuals are approved for reclassification:
- Krishna Vrundavandas Valia
- Sudhir Vrundavandas Valia
- Raksha Sudhir Valia
Background and Timeline
This intimation follows earlier company disclosures made on:
- 14 May 2026
- 22 May 2026
- 26 May 2026 (formal application date referenced in both exchange letters)
The company applied for reclassification on 26 May 2026, and received approvals from both exchanges on 06 August 2026.
Compliance Requirements
Both exchange letters specify that the company must ensure compliance with subsequent relevant disclosures of material events related to this reclassification, in accordance with the applicable provisions of Regulation 31A of SEBI Listing Regulations.
Additional Information
Copies of the no-objection letters from NSE and BSE are attached as Annexure A and Annexure B respectively, and are also available on the Company's website at www.sunpharma.com.
The NSE reference number is: NSE/LIST/COMP/SUNPHARMA/600/2026-2027
The BSE reference number is: LIST/COMP/KR/163/2026-27